黄山胶囊收盘下跌1.12%，滚动市盈率44.84倍，总市值23.66亿元

Company Overview - Huangshan Capsule Co., Ltd. specializes in the research, production, and sales of gelatin hollow capsules and enteric-coated gelatin hollow capsules, with over 30 years of high-quality production history [1] - The company is one of the earliest manufacturers of pharmaceutical hollow capsules in China and has a high reputation in the industry [1] Financial Performance - For Q1 2025, the company reported operating revenue of 119 million yuan, a year-on-year increase of 0.53%, and a net profit of 18.837 million yuan, up 22.90% year-on-year [2] - The sales gross margin for the same period was 29.26% [2] Market Position - The company's current price-to-earnings (PE) ratio is 44.84, compared to the industry average of 54.89 and the industry median of 37.06 [2] - Huangshan Capsule's total market capitalization is 2.366 billion yuan [1] Industry Context - The medical device industry, where Huangshan Capsule operates, has an average PE ratio of 54.89 and a median of 37.06 [2] - Huangshan Capsule ranks 83rd in terms of PE ratio within its industry [1] Capital Flow - On July 31, the company experienced a net outflow of main funds amounting to 2.725 million yuan, with a total outflow of 3.7357 million yuan over the past five days [1]